ConductScience.org, home

Paper33005474

MiR-22 as a metabolic silencer and liver tumor suppressor.

Wang L and 4 others. Liver Res, 2020. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. MiR-22 as a metabolic silencer and liver tumor suppressor. Papers, record 33005474. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33005474

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
MiR-22 as a metabolic silencer and liver tumor suppressor.
PubMed
Journal
Liver Res
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
1.07
iCite
Revised in PubMed
2021-06-02
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang LLijun
2Wang YSYu-Shiuan
3Mugiyanto EEko
4Chang WCWei-Chiao
5Yvonne Wan YJYu-Jui

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA222490NCI NIH HHSUnited StatesR01CA222490PubMed and NIHNIH RePORTER
U01 CA179582NCI NIH HHSUnited StatesU01CA179582PubMed and NIHNIH RePORTER

Download CSV of grants

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116469768
Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator of transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis.
Mol Endocrinol2006https://conductscience.org/library/papers/16469768PubMed
220600201Testosterone-induced upregulation of miRNAs in the female mouse liver.Steroids2010https://conductscience.org/library/papers/20600201PubMed
323508904Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B.J Med Virol2013https://conductscience.org/library/papers/23508904PubMed
422528874Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression.Cancer Microenviron2012https://conductscience.org/library/papers/22528874PubMed
530083257Identification and Functional Characterization of Long Non-coding RNA MIR22HG as a Tumor Suppressor for Hepatocellular Carcinoma.Theranostics2018https://conductscience.org/library/papers/30083257PubMed
615788153Testosterone responsiveness of spleen and liver in female lymphotoxin beta receptor-deficient mice resistant to blood-stage malaria.Microbes Infect2005https://conductscience.org/library/papers/15788153PubMed
725125218Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients.Hepatology2015https://conductscience.org/library/papers/25125218PubMed
828288414Butyrate induces ROS-mediated apoptosis by modulating miR-22/SIRT-1 pathway in hepatic cancer cells.Redox Biol2017https://conductscience.org/library/papers/28288414PubMed
931145886Catalpol inhibits cell proliferation, invasion and migration through regulating miR-22-3p/MTA3 signalling in hepatocellular carcinoma.Exp Mol Pathol2019https://conductscience.org/library/papers/31145886PubMed
1030252536RARβ acts as both an upstream regulator and downstream effector of miR-22, which epigenetically regulates NUR77 to induce apoptosis of colon cancer cells.FASEB J2019https://conductscience.org/library/papers/30252536PubMed
1130365068Galectin-1 gene silencing inhibits the activation and proliferation but induces the apoptosis of hepatic stellate cells from mice with liver fibrosis.Int J Mol Med2019https://conductscience.org/library/papers/30365068PubMed
1223091627Hepatitis B virus-specific miRNAs and Argonaute2 play a role in the viral life cycle.PLoS One2012https://conductscience.org/library/papers/23091627PubMed
1321798241MicroRNA-22 and microRNA-140 suppress NF-κB activity by regulating the expression of NF-κB coactivators.Biochem Biophys Res Commun2011https://conductscience.org/library/papers/21798241PubMed
141334694Hepatocellular carcinoma and sex hormones.HPB Surg1992https://conductscience.org/library/papers/1334694PubMed
1528000852Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review).Int J Oncol2017https://conductscience.org/library/papers/28000852PubMed
1630731163Prognostic value and oncogene function of heterogeneous nuclear ribonucleoprotein A1 overexpression in HBV-related hepatocellular carcinoma.Int J Biol Macromol2019https://conductscience.org/library/papers/30731163PubMed
1725826372MicroRNA-22 impairs anti-tumor ability of dendritic cells by targeting p38.PLoS One2015https://conductscience.org/library/papers/25826372PubMed
1820200618Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness.Mol Med2010https://conductscience.org/library/papers/20200618PubMed
1930562963Oncogenic Activation of Nrf2, Though as a Master Antioxidant Transcription Factor, Liberated by Specific Knockout of the Full-Length Nrf1α that Acts as a Dominant Tumor Repressor.Cancers (Basel)2018https://conductscience.org/library/papers/30562963PubMed
2025452043Differences in serum microRNA profiles in hepatitis B and C virus infection.J Infect2015https://conductscience.org/library/papers/25452043PubMed

See all 57 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42597973Multidimensional perspectives on cancer therapy-induced cardiotoxicity: Characteristics, mechanisms, biomarkers, psychological stress effects, and treatment progress.Cancer Pathog Ther2026https://conductscience.org/library/papers/42597973PubMed
41540504miR-22-Galectin-1 as an integral signaling axis in regulating metabolism and immunity in HCC.Biomark Res2026https://conductscience.org/library/papers/41540504PubMed
40636409Free fatty acid-induced miR-22 inhibits gluconeogenesis via SIRT-1-mediated PGC-1α expression in nonalcoholic fatty liver disease.ILIVER2023https://conductscience.org/library/papers/40636409PubMed
40350013Per- and polyfluoroalkyl substances (PFAS) and microRNA: An epigenome-wide association study in firefighters.Environ Res2025https://conductscience.org/library/papers/40350013PubMed
39859495The Role of microRNA-22 in Metabolism.Int J Mol Sci2025https://conductscience.org/library/papers/39859495PubMed
39022683The interregulatory circuit between non-coding RNA and apoptotic signaling in diabetic cardiomyopathy.Noncoding RNA Res2024https://conductscience.org/library/papers/39022683PubMed
38952162Review of the Different Outcomes Produced by Genetic Knock Out of the Long Non-coding microRNA-host-gene MIR22HG versus Pharmacologic Antagonism of its Intragenic microRNA product miR-22-3p.Microrna2025https://conductscience.org/library/papers/38952162PubMed
38289119MicroRNA-22-3p displaces critical host factors from the 5' UTR and inhibits the translation of Coxsackievirus B3 RNA.J Virol2024https://conductscience.org/library/papers/38289119PubMed
37905655Evaluation of the Relationship Between miRNA-22-3p and Gal-9 Levels in Glioblastoma.In Vivo2023https://conductscience.org/library/papers/37905655PubMed
37893134Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors.Biomedicines2023https://conductscience.org/library/papers/37893134PubMed
37143325miR-22 gene therapy treats HCC by promoting anti-tumor immunity and enhancing metabolism.Mol Ther2023https://conductscience.org/library/papers/37143325PubMed
37033600Assessment of immunostimulatory responses to the antimiR-22 oligonucleotide compound RES-010 in human peripheral blood mononuclear cells.Front Pharmacol2023https://conductscience.org/library/papers/37033600PubMed
36749775Hsa-miR-22-3p inhibits liver cancer cell EMT and cell migration/ invasion by indirectly regulating SPRY2.PLoS One2023https://conductscience.org/library/papers/36749775PubMed
36551740An Immunocompetent Environment Unravels the Proto-Oncogenic Role of miR-22.Cancers (Basel)2022https://conductscience.org/library/papers/36551740PubMed
36139435MiR-22 Deficiency Fosters Hepatocellular Carcinoma Development in Fatty Liver.Cells2022https://conductscience.org/library/papers/36139435PubMed
34567824Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma.Liver Res2020https://conductscience.org/library/papers/34567824PubMed
34403532AC016405.3 functions as an oncogenic long non-coding RNA by regulating ERBB3 via sponging miR-22-3p in breast cancer.J Clin Lab Anal2021https://conductscience.org/library/papers/34403532PubMed
34062897GeromiRs Are Downregulated in the Tumor Microenvironment during Colon Cancer Colonization of the Liver in a Murine Metastasis Model.Int J Mol Sci2021https://conductscience.org/library/papers/34062897PubMed
33343967Hepatocellular carcinoma immunotherapy: The impact of epigenetic drugs and the gut microbiome.Liver Res2020https://conductscience.org/library/papers/33343967PubMed

Download CSV of cited by

Genes60

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACTA158PubTator's text mininghttps://conductscience.org/library/genes/58NCBI Gene
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174NCBI Gene
AKT2208PubTator's text mininghttps://conductscience.org/library/genes/208NCBI Gene
ALDH1A1216PubTator's text mininghttps://conductscience.org/library/genes/216NCBI Gene
BMP7655PubTator's text mininghttps://conductscience.org/library/genes/655NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CCL26347PubTator's text mininghttps://conductscience.org/library/genes/6347NCBI Gene
CCNA2890PubTator's text mininghttps://conductscience.org/library/genes/890NCBI Gene
CYCS54205PubTator's text mininghttps://conductscience.org/library/genes/54205NCBI Gene
DES1674PubTator's text mininghttps://conductscience.org/library/genes/1674NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EP3002033PubTator's text mininghttps://conductscience.org/library/genes/2033NCBI Gene
FGF2126291PubTator's text mininghttps://conductscience.org/library/genes/26291NCBI Gene
FGFR12260PubTator's text mininghttps://conductscience.org/library/genes/2260NCBI Gene
GABPA2551PubTator's text mininghttps://conductscience.org/library/genes/2551NCBI Gene
GGTLC192086PubTator's text mininghttps://conductscience.org/library/genes/92086NCBI Gene
GPT2875PubTator's text mininghttps://conductscience.org/library/genes/2875NCBI Gene
GREM126585PubTator's text mininghttps://conductscience.org/library/genes/26585NCBI Gene
HDAC13065PubTator's text mininghttps://conductscience.org/library/genes/3065NCBI Gene
HDAC49759PubTator's text mininghttps://conductscience.org/library/genes/9759NCBI Gene

See all 60 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33005474

GET https://conductscience.org/api/papers/v1/33005474/references?page=2